Zai Lab sees profits on the horizon as commercialization accelerates
The innovative drug maker’s loss narrowed last year, as it forecast potential profitability as soon as 2025 on fast-growing revenues Key Takeaways: Zai Lab is set to reach several product…
9688.HK
ZLAB.US
Recent Articles
RELATED ARTICLES
-
Joinn profits slide as lab monkey build-up backfires
6127.HK 603127.SHG
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
FAST NEWS: Zai Lab’s loss narrows on strengthening sales
9688.HK ZLAB.US
-
FAST NEWS: Zai Lab’s loss narrows on growing revenue
ZLAB.US 9688.HK
-
CStone breaks up with drugs partner as U.S. rollout stalls
2616.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
Discover hidden China stock gems in our weekly newsletter